Sezioni unite; udienza 31 marzo 1941, n. 928; Pres. D'Amelio P.P., Est. Piacentini, P. M. Terra Abrami (concl. conf.); Falcone (Avv. Conte, Oneto) c. Comune di Chiavari (Avv. Troiani)

Publikováno v: Il Foro Italiano, 1941 Jan 01. 66, 607/608-611/612.

Externí odkaz: https://www.jstor.org/stable/23133187

Sezione I civile; udienza 10 luglio 1935; Pres. Scalfaro P., Est. Galizia, P. M. Ferroni (concl. diff.); Berlingeri (Avv. Queirolo, Oneto) c. Banca d' Italia (Avv. Jermini, Grego)

Publikováno v: Il Foro Italiano, 1935 Jan 01. 60, 1057/1058-1059/1060.

Externí odkaz: https://www.jstor.org/stable/23130486

Udienza 26 agosto 1911; Pres. Pignolo, Est. Campora; Ditta Oneto c. Rebaudi e Corradi

Publikováno v: Il Foro Italiano, 1912 Jan 01. 37, 103/104-107/108.

Externí odkaz: https://www.jstor.org/stable/23113704

Single-Cell RNA Sequencing Shows that Circulating Monocytes Enriched in IFN Signaling Are Associated with Nontuberculous Mycobacteria Pulmonary Disease in Cystic Fibrosis.

Autor: Lorè NI; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy., Gramegna A; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.; Respiratory Unit and Adult Cystic Fibrosis Center and., de Pretis S; Center for Omics Sciences, IRCCS San Raffaele Institute, Milan, Italy., Di Marco F; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy., Giannese F; Center for Omics Sciences, IRCCS San Raffaele Institute, Milan, Italy., Saliu F; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy., Oneto C; Center for Omics Sciences, IRCCS San Raffaele Institute, Milan, Italy., Contarini M; Respiratory Unit and Adult Cystic Fibrosis Center and., Cariani L; SC Clinical Pathology, Laboratory of Microbiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; and., Blasi F; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.; Respiratory Unit and Adult Cystic Fibrosis Center and., Cirillo DM; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Sep 15; Vol. 210 (6), pp. 834-837.

Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.

Autor: Berenson CS; Veterans Affairs Western New York Healthcare System, University at Buffalo, New York, New York, USA., Lashner B; Gastroenterology Division, Cleveland Clinic, Ohio, USA., Korman LY; Gastroenterology and Hepatology, Chevy Chase Clinical Research, Chevy Chase, Maryland, USA., Hohmann E; Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA., Deshpande A; Gastroenterology Division, Cleveland Clinic, Ohio, USA., Louie TJ; Department of Microbiology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Alberta, Canada., Sims M; Section of Infectious Diseases and International Medicine, Department of Internal Medicine, Beaumont Royal Oak, Royal Oak, Michigan, USA.; Departments of Internal Medicine and Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, Michigan, USA., Pardi D; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Kraft CS; Division of Infectious Diseases, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA., Wang EEL; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., Cohen SH; Division of Infectious Diseases, University of California, Davis Health, Sacramento, California, USA., Feuerstadt P; Division of Digestive Disease, Yale University School of Medicine, New Haven, Connecticut, USA.; Division of Gastroenterology, Yale University and PACT-Gastroenterology Center, Hamden, Connecticut, USA., Oneto C; Vanguard Gastroenterology, New York, New York, USA., Misra B; Borland-Groover Clinic, P.A., Jacksonville, Florida, USA., Pullman J; Mercury Street Medical, Butte, Montana, USA., De A; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., Memisoglu A; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., Lombardi DA; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., Hasson BR; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., McGovern BH; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., von Moltke L; Clinical Development, Seres Therapeutics, Cambridge, Massachusetts, USA., Lee CH; Department of Microbiology and Infectious Diseases, Island Medical Program, University of British Columbia and University of Victoria, British Columbia, Canada.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Nov 30; Vol. 77 (11), pp. 1504-1510.